27th May 2021 09:32
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
BARCLAYS RAISES AVEVA TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 4,060 (3,730) PENCE
----------
HSBC RAISES SEVERN TRENT TO 'BUY' ('HOLD') - TARGET 2,780 (2,570) PENCE
----------
RBC RAISES M&G PRICE TARGET TO 260 (230) PENCE - 'OUTPERFORM'
----------
MORGAN STANLEY RAISES BRITISH LAND TARGET TO 450 (410) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1,542 (1,423) PENCE - 'NEUTRAL'
----------
DZ BANK RAISES FAIR VALUE FOR ASTRAZENECA TO 6,900 (6,500) PENCE - 'SELL'
----------
FTSE 250
----------
PANMURE CUTS VECTURA GROUP TO 'HOLD' ('BUY') - TARGET 155 (149) PENCE
----------
JEFFERIES RAISES MARKS & SPENCER PRICE TARGET TO 200 (180) PENCE - 'BUY'
----------
GOLDMAN RAISES MARKS & SPENCER PRICE TARGET TO 180 (165) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES MARKS & SPENCER PRICE TARGET TO 200 (165) PENCE - 'OVERWEIGHT'
----------
LIBERUM INITIATES CENTAMIN WITH 'SELL' - TARGET 82 PENCE
----------
UBS RAISES MEGGITT TO 'NEUTRAL' ('SELL') - TARGET 491 (359) PENCE
----------
OTHER MAIN MARKET AND AIM
----------
BERENBERG RAISES IMPAX GROUP PRICE TARGET TO 1,310 (1,250) PENCE - 'BUY'
----------
BERENBERG RESUMES XLMEDIA WITH 'BUY' - TARGET 76 PENCE
----------
LIBERUM RAISES GYM GROUP PRICE TARGET TO 325 (295) PENCE - 'BUY'
----------
BARCLAYS RAISES GYM GROUP PRICE TARGET TO 320 (265) PENCE - 'OVERWEIGHT'
----------
JEFFERIES RAISES SPIRE HEALTHCARE PRICE TARGET TO 240 (159) PENCE - 'HOLD'
----------
PEEL HUNT CUTS SPIRE HEALTHCARE TO 'HOLD' ('BUY') - TARGET 240 (233) PENCE
----------
RBC CUTS SPIRE HEALTHCARE TO 'SECTOR PERFORM' (OUTPERFORM) - TARGET 240 (200) PENCE
----------
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
AstrazenecaVEC.LImpax Asset ManagementSmith & NephewBritish LandCentamin PLCXlmediaAVV.LMarks & SpencerSpire HealthcareMGGT.LGym GrpSevern TrentM&G